BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 444305)

  • 1. 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine.
    Löscher W
    Biochem Pharmacol; 1979 Apr; 28(8):1397-407. PubMed ID: 444305
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine.
    Bernasconi R; Maitre L; Martin P; Raschdorf F
    J Neurochem; 1982 Jan; 38(1):57-66. PubMed ID: 7108535
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminooxyacetic acid: correlation between biochemical effects, anticonvulsant action and toxicity in mice.
    Löscher W; Frey HH
    Biochem Pharmacol; 1978 Jan; 27(1):103-8. PubMed ID: 619891
    [No Abstract]   [Full Text] [Related]  

  • 4. The gamma-aminobutyrate content of nerve endings (synaptosomes) in mice after the intramuscular injection of gamma-aminobutyrate-elevating agents: a possible role in anticonvulsant activity.
    Wood JD; Russell MP; Kurylo E
    J Neurochem; 1980 Jul; 35(1):125-30. PubMed ID: 7452248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aminooxyacetic acid on in vivo gamma-aminobutyric acid system of rat oviduct.
    Martin de Rio R; López MS
    Gen Pharmacol; 1983; 14(2):281-3. PubMed ID: 6840511
    [No Abstract]   [Full Text] [Related]  

  • 7. Gabuculine and isogabaculine: in vivo biochemistry and pharmacology in mice.
    Schechter PJ; Tranier Y; Grove J
    Life Sci; 1979 Mar; 24(13):1173-82. PubMed ID: 449617
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined effects of a metabolic inhibitor (gabaculine) and an uptake inhibitor (ketamine) on the gamma-aminobutyrate system in mouse brain.
    Wood JD; Geddes JW; Tsui SK; Kurylo E
    J Neurochem; 1982 Dec; 39(6):1710-5. PubMed ID: 7142997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the irreversible inhibition of 4-aminobutyric acid:2-oxoglutarate and L-ornithine:2-oxoacid aminotransferases by 3-amino-1,5-cyclohexadienyl carboxylic acid (isogabaculline).
    Metcalf BW; Jung MJ
    Mol Pharmacol; 1979 Sep; 16(2):539-45. PubMed ID: 514257
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral endothelial GABA-T activity: effects of in vivo GABA-T inhibition.
    Krantis A
    Neurosci Lett; 1986 Jun; 67(1):48-52. PubMed ID: 3725199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gabaculine, a new potent inhibitor of gamma-amonobutyrate transaminase, on the brain gamma-amonobutyrate content and convulsions in mice.
    Matsui Y; Deguchi T
    Life Sci; 1977 Apr; 20(7):1291-5. PubMed ID: 850479
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain.
    Löscher W; Frey HH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):263-9. PubMed ID: 840320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The irreversible inhibition of mouse brain gamma-aminobutyric acid (GABA)-alpha-ketoglutaric acid transaminase by gabaculine.
    Rando RR; Bangerter FW
    J Am Chem Soc; 1976 Oct; 98(21):6762-4. PubMed ID: 972233
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminooxyacetic acid induced changes in gamma-aminobutyrate metabolism at the subcellular level.
    Wood JD; Kurylo E; Newstead JD
    Can J Biochem; 1978 Jun; 56(6):667-72. PubMed ID: 667703
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of inhibitors of gamma-aminobutyric acid (GABA) transaminase for the estimation of GABA turnover in various brain regions of rats: a reevaluation of aminooxyacetic acid.
    Löscher W; Hönack D; Gramer M
    J Neurochem; 1989 Dec; 53(6):1737-50. PubMed ID: 2809589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo inhibition of GABA-transaminase by gabaculine.
    Rando RR; Bangerter FW
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1276-81. PubMed ID: 901477
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of gabaculine on metabolism and release of gamma-aminobutyric acid in synaptosomes.
    Asakura T; Matsuda M
    Neurochem Res; 1990 Mar; 15(3):295-300. PubMed ID: 1973270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of [3H]gamma-vinyl-GABA to GABA-transaminase in brain homogenates.
    Gale K
    Life Sci; 1984 Feb; 34(7):701-6. PubMed ID: 6700374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant activity of aminooxyacetic acid on convulsions induced by thiosemicarbazide.
    Murakami Y; Abe M; Murakami K
    J Neurochem; 1976 Mar; 26(3):655-6. PubMed ID: 1262886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.